The investigators have found that obese hypertensives have increased vascular alpha-adrenergic tone and elevated plasma non-esterified fatty acids (NEFAs). The increased alpha-adrenoceptor tone and NEFAs may be linked , since they have shown that raising NEFAs in lean normotensives enhanced local venoconstrictor and systemic pressor responses to phenylephrine, an alpha 1-adrenoceptor agonist. Indomethacin reversed the augmented venoconstrictor response to phenylephrine when NEFAs were raised locally. This project is designed to test the hypothesis: Fatty acids increase vascular alpha 1-adrenoceptor pressor reactivity. The project has four Aims: 1. Determine if raising NEFAs increases and lower NEFAs reduces pressor reactivity to phenylephrine similarly in volunteers differing by body mass index, body fat distribution, and blood pressure. Vascular alpha 1-adrenoceptor reactivity, assessed by changes in phenylephrine dose which raises mean BP 20 mmHg, is measured on separate days at baseline and after raising NEFAs (intralipid/heparin) and lowering NEFAs (nicotinic acid). 2. Determine if interactions between obesity, fat distribution, hypertension and PD-20 are related to insulin's action on NEFA concentrations and turnover rather than glucose disposal. The studies for Aim 1 will be performed in lean normotensives, lower body obese normotensives (to control for obesity), abdominally obese normotensives (to control for body fat distribution), lean hypertensives (to control for BP), and abdominally obese hypertensives. 3. Determine the effects of cyclo-oxygenase inhibition with indomethacin on pressor responsiveness to phenylephrine when NEFAs are elevated with intralipid/heparin. Changes in the PD-20 induced by intralipid/heparin will be compared to changes on other days when intralipid/heparin is given with indomethacin and also indomethacin alone to block generation of cyclo-oxygenase products. 4 Contrast the effects of raising plasma linoleate, oleate, and palmitate levels with intralipid/heparin to those of selectively raising plasma oleate (triolein/heparin), linoleate (trilinolein/heparin), and saturated NEFAs (coconut oil/heparin) on the PD-20. The investigators propose that these studies could better delineate the short-term effects of specific NEFAs, and possibly cyclo-oxygenase products, in the heightened neurovascular reactivity and tone which characterize obesity hypertension. The studies could provide a basis for longer-term clinical studies on NEFAs and BP regulation as well as basic experiments to elucidate signaling mechanisms.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL058794-03
Application #
6030848
Study Section
Cardiovascular and Renal Study Section (CVB)
Project Start
1997-08-15
Project End
2002-03-31
Budget Start
1999-07-01
Budget End
2002-03-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Pharmacology
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Al-Solaiman, Y; Jesri, A; Mountford, W K et al. (2010) DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens 24:237-46
Al-Solaiman, Y; Jesri, A; Zhao, Y et al. (2009) Low-Sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans. J Hum Hypertens 23:826-35
King, Dana E; Mainous 3rd, Arch G; Egan, Brent M et al. (2008) Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM). Ann Fam Med 6:100-6
King, Dana E; Egan, Brent M; Woolson, Robert F et al. (2007) Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med 167:502-6
Okonofua, Eni C; Simpson, Kit N; Jesri, Ammar et al. (2006) Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 47:345-51
Taylor, Timothy P; Wang, Wei; Shrayyef, M Zakarea et al. (2006) Glomerular filtration rate can be accurately predicted using lean mass measured by dual-energy X-ray absorptiometry. Nephrol Dial Transplant 21:84-7
Jesri, Ammar; Okonofua, Eni C; Egan, Brent M (2005) Platelet and white blood cell counts are elevated in patients with the metabolic syndrome. J Clin Hypertens (Greenwich) 7:705-11; quiz 712-3
Egan, Brent M; Papademetriou, Vasilios; Wofford, Marion et al. (2005) Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure. Am J Hypertens 18:3-12
Rehman, Shakaib U; Hutchison, Florence N; Hendrix, Katharine et al. (2005) Ethnic differences in blood pressure control among men at Veterans Affairs clinics and other health care sites. Arch Intern Med 165:1041-7
Liszka, Heather A; Mainous 3rd, Arch G; King, Dana E et al. (2005) Prehypertension and cardiovascular morbidity. Ann Fam Med 3:294-9

Showing the most recent 10 out of 27 publications